<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000373995"><TermName>NBI-3001</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is made by combining interleukin-4 with a bacterial toxin. NBI-3001 is a type of recombinant chimeric protein. Also called interleukin-4 PE38KDEL cytotoxin and interleukin-4 PE38KDEL immunotoxin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>NBI-3001</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Está hecha de una combinación de interleucina 4 con una toxina bacteriana. NBI-3001 es un tipo de proteína quimérica recombinante. También se llama interleucina-4 PE30KDEL inmunotoxina y interleucina-4 PE38KDEL citotoxina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-06-23</DateFirstPublished><DateLastModified>2007-04-06</DateLastModified></GlossaryTerm>
